REMOTE OBSERVED DOSING TO IMPROVE SUBOXONE COMPLIANCE IN CLINICAL PRACTICE

The RODS study offers 12 weeks of Suboxone treatment. Suboxone is an FDA approved medication used to treat opioid use disorder. While the medication phase last 12 weeks, the study takes 15 weeks all together. You will be under a clinician care throughout the course of the study. There is a baseline screening visit that includes bloodwork, a urine drug test, physical exam, and questionnaires. Participants will be randomly (similar to flipping a coin) assigned to one of two groups: the remote observed dosing group or the attention control group. The remote observed dosing group will submit daily video recordings of themselves taking their Suboxone dose. The attention control group will complete daily surveys confirming that they have taken their daily Suboxone dose. Both groups receive 12-weeks of Suboxone as well as a study phone with a capped talk, text, and data plan that is yours to keep after study completion. Suboxone induction will occur across three hour-long visits. Following induction, participants will come in twice a week for 30-45 minute study visits. A urine sample will be collected at every visit.